ImmuPharma - Re: IMM Stream Log - Panmure published a note this...

Live Discuss Polls Ratings Documents
View
Page
12:35 07/06/2016

Panmure published a note this morning on Research Tree: "This morning ImmuPharma has announced the commencement of dosing in the first European patients in the company’s pivotal Phase III clinical study for Lupuzor™. This means that both US and European sites are now dosing patients in the Phase III trial (recruitment is expected in up to 45 investigator sites) and with Lupus continuing to represent a major unmet medical need we consider the ongoing demand for an effective treatment – highlighted by still torpid sales of GSK’s Benlysta – represents a major opportunity for ImmuPhara."

Page